Federation Des Caisses Desjardins Du Quebec Legend Biotech Corp Transaction History
Federation Des Caisses Desjardins Du Quebec
- $21.3 Billion
- Q2 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Legend Biotech Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 253 shares of LEGN stock, worth $8,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
253
Previous 452
44.03%
Holding current value
$8,149
Previous $15,000
46.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LEGN
# of Institutions
237Shares Held
60MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$223 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$193 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$184 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$122 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$95.4 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.39B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...